The effect of atorvastatin on the level of inflammatory marker and right ventricular function in chronic obstructive pulmonary disease patients
Not Applicable
- Conditions
- chronic obstructive pulmonary disease.?????? ??????? ???? ??????????? ???? ????? ?? ?????? ??????? ???? ??? ????? ?????????? ?? ?????? ??????? ???? ??? ??????????ICD-10-CM
- Registration Number
- IRCT201108177356N1
- Lead Sponsor
- Vice Chancellor for research of Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
inclusion criteria: having stable chronic obstructive pulmonary disease for at least 3 month
exclusion criteria: having coronary artery disease, using medication for reducing lipid profile; having atrial fibrilation rhythm; having active liver disease; having active infection; having malignancy; having connective tissue diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Right ventricle systolic function. Timepoint: 3 months after intervention. Method of measurement: tissue duppler and speckle tracking echocardiography.
- Secondary Outcome Measures
Name Time Method High sensitive C reactive protein. Timepoint: 3 months after intervention. Method of measurement: blood sample.